Time to abandon three-phase trials?

BMJ. 2016 Feb 17:352:i764. doi: 10.1136/bmj.i764.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clinical Trials, Phase I as Topic*
  • Drug-Related Side Effects and Adverse Reactions*
  • Healthy Volunteers*
  • Humans
  • Risk Assessment*